Long-Term Outcomes and Prognostic Analysis of Endometrial Cancer: A 10-Year Tertiary Care Experience
References
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2022. CA Cancer J Clin. 2023;73:17–48.
- International Agency for Research on Cancer. GLOBOCAN 2022: Pakistan Fact Sheet. Lyon: IARC; 2024.
- Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012;120:383–97.
- Morice P, Leary A, Creutzberg C, et al. Endometrial cancer. Lancet. 2016;387:1094–1108.
- Colombo N, Creutzberg C, Amant F, et al. ESMO–ESGO–ESTRO consensus conference on endometrial cancer. Int J Gynecol Cancer. 2016;26:2–30.
- Maheshwari A, Kumar N, et al. Endometrial cancer in Asia. Int J Gynecol Cancer. 2016;26:1303–9.
- Goel P, Singh V, Sharma R, et al. Early endometrial carcinoma outcomes. J Cancer Res Ther. 2023;19(Suppl 1):S318–22.
- Setakornnukul J, Petsuksiri J, et al. Long-term outcomes of patients with endometrial carcinoma treated with radiation. Asian Pac J Cancer Prev. 2014;15:2279–85.
- Yamaguchi M, Kushiya N, Tamura R, et al. Trends in endometrial carcinoma: Experience of a single institute for four decades. Jpn J Clin Oncol. 2024;54:599–605.
- Jamal S, Mamun AA, Khan S. Endometrial carcinoma: Five-year experience at a tertiary care hospital in Pakistan. J Ayub Med Coll Abbottabad. 2010;22:97–100.
- Sultana N, Akram M, Wani A, et al. Clinicopathological profile of endometrial carcinoma at a tertiary care center in Pakistan. Pak J Med Sci. 2016;32:206–10.
- Yusuf AW, Wazir F, Mushtaq S. Endometrial adenocarcinoma: A clinicopathological study of 80 cases. J Pak Med Assoc. 2013;63:1092–5.
- Mahmood H, Rehman S, Qureshi S, et al. Presentation and treatment patterns in endometrial carcinoma at a tertiary care oncology center. J Coll Physicians Surg Pak. 2019;29:314–8.
- FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the corpus uteri. Int J Gynecol Obstet. 2009;105:109.
- Keys HM, Roberts JA, Brunetto VL, et al. GOG-99: A phase III trial of surgery ± pelvic radiation therapy in intermediate-risk endometrial carcinoma. Gynecol Oncol. 2004;92:744–51.
- Creutzberg CL, van Putten WLJ, Koper PC, et al. PORTEC-1: Postoperative radiotherapy in endometrial carcinoma. Lancet. 2000;355:1404–11.
- Nout RA, Smit VT, Putter H, et al. PORTEC-2: Vaginal brachytherapy versus pelvic radiotherapy in high-intermediate-risk endometrial carcinoma. Lancet. 2010;375:816–23.
- de Boer SM, Powell ME, Mileshkin LR, et al. PORTEC-3: Chemoradiotherapy versus radiotherapy for high-risk endometrial cancer. Lancet Oncol. 2018;19:295–309.
- Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. Global patterns and trends in endometrial cancer incidence and survival. Int J Cancer. 2018;143:2237–48.
- NCCN Clinical Practice Guidelines in Oncology. Uterine Neoplasms. Version 2024.
- Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynecol Obstet. 2009;105:109.
- Wright JD, Barrena Medel NI, Sehouli J, et al. Contemporary management of endometrial cancer. Lancet. 2009;374:833–46.
- Fader AN, et al. Clear cell carcinoma of the uterus. Gynecol Oncol. 2010;116:10–6.
- Reed NS, Mangioni C, Malmström H, et al. Uterine sarcomas: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29:iv51–iv60.
- Renehan AG, Tyson M, Egger M, et al. Body-mass index and cancer incidence: A systematic review and meta-analysis. Lancet. 2008;371:569–78.
- Crosbie EJ, Zwahlen M, et al. Body mass index and endometrial cancer risk. Lancet Oncol. 2010;11:673–84.
- Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10–7.
- D’Angelo E, Prat J. Uterine sarcomas: Diagnosis and management. Gynecol Oncol. 2010;116:131–9.
- Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491–505.
- Lewin SN, et al. Survival by stage in endometrial cancer. Gynecol Oncol. 2010;119:15–20.
- Guntupalli SR, Zighelboim I, et al. Lymphovascular space invasion and survival outcomes. Gynecol Oncol. 2012;124:31–5.
- Dos Reis R, et al. LVSI in low-risk endometrial carcinoma. Int J Gynecol Cancer. 2015;25:1292–9.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
- Makker V, Taylor MH, Aghajanian C, et al. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer. N Engl J Med. 2022;386(5):437–448.
DOI: https://doi.org/10.2478/jcas-2026-0015 | Journal eISSN: 2411-989X
Language: English
Page range: 97 - 104
Published on: Sep 1, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Sadia Anjum, Anas Tahseen, Aqueel Shahid, Tabinda Sadaf, Anusha Haider, Abdul Subhan, Rameesha Jahangir, Fajar Rafi Ranjha, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.